Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Venture Life ( (GB:VLG) ) has shared an announcement.
Venture Life Group plc, a UK-headquartered consumer self-care and healthcare products group, has continued its previously announced share buyback programme with the repurchase of 200,000 ordinary shares at a volume-weighted average price of 65.88 pence per share, with the shares to be held in treasury. Following this transaction, the company now has 128,812,145 ordinary shares in issue, of which 3,709,196 are held in treasury, leaving 125,102,949 voting shares outstanding, a change that slightly reduces the free float and may affect existing shareholders’ percentage holdings and related disclosure obligations under the FCA’s transparency rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £65.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Spark’s Take on GB:VLG Stock
According to Spark, TipRanks’ AI Analyst, GB:VLG is a Neutral.
Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.
To see Spark’s full report on GB:VLG stock, click here.
More about Venture Life
Venture Life Group plc is an international consumer self-care company in the global consumer healthcare sector, focused on proactive healthy longevity and the commercialisation of over-the-counter health and wellbeing products. Headquartered in the UK, its portfolio includes brands such as Balance Activ in women’s intimate healthcare, Earol for ENT care, Lift and Glucogel for energy and glucose management and hypoglycaemia, and the Health & Her range supporting the hormonal lifecycle, sold through pharmacies, health and beauty retailers, grocery chains and e-commerce, both directly in key markets and via international distribution partners elsewhere.
Average Trading Volume: 227,042
Technical Sentiment Signal: Buy
Current Market Cap: £82.42M
See more insights into VLG stock on TipRanks’ Stock Analysis page.